Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Eduardo Reyes-Sánchez"'
Autor:
María G. C. Navarrete-Bernal, Mayte G. Cervantes-Badillo, Jose Fabián Martínez-Herrera, César O. Lara-Torres, Raquel Gerson-Cwilich, Alejandro Zentella-Dehesa, María de Jesús Ibarra-Sánchez, José Esparza-López, Juan J. Montesinos, Víctor Adrián Cortés-Morales, Diego Osorio-Pérez, Diana A. Villegas-Osorno, Eduardo Reyes-Sánchez, Pablo Salazar-Sojo, Luis F. Tallabs-Utrilla, Sandra Romero-Córdoba, Leticia Rocha-Zavaleta
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Patients with triple-negative breast cancer (TNBC) have a poor prognosis, partly because of the absence of targeted therapies. Recognition of the key role of immune responses against cancer has allowed the advent of immunotherapy, focused on the inhi
Externí odkaz:
https://doaj.org/article/f15f17fd5d6c4186a7abe754e5cbd50e
Autor:
Guillermo Olivares-Beltrán, José Miguel Lázaro-León, Christian Patricio Camacho-Limas, Álvaro Padilla-Rodríguez, Alberto Villalobos-Prieto, Juan Alberto Serrano-Olvera, Fernando Perez-Zincer, Geovani Amador-García, Raúl Alejandro Andrade-Moreno, Álvaro Aguayo-González, Lorena López-Zepeda, Raquel Gerson-Cwilich, Daniela Vázquez-Juárez, José Fabián Martínez-Herrera, Elina Rodríguez-Meléndez, Eduardo Reyes-Sánchez
Publikováno v:
Cancer Research. 80:P3-07
Introduction: Breast cancer represents the most frequently neoplasm diagnosed in women. Early breast cancer (EBC) occurs in 36-50% of cases, with recurrence rates of more than 20% at 10 years in our country. Adjuvant chemotherapy reduces recurrence r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efbea523bd4c815509dcd470b124c62d
https://doi.org/10.1158/1538-7445.sabcs19-p3-07-12
https://doi.org/10.1158/1538-7445.sabcs19-p3-07-12